Michael Gale Selected Research

Biomarkers (Surrogate Marker)

1/2018	Femur-sparing pattern of abnormal fetal growth in pregnant women from New York City after maternal Zika virus infection.
1/2017	Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Gale Research Topics

Disease

118	Infections 10/2023 - 04/2003
61	Virus Diseases (Viral Diseases) 01/2023 - 03/2002
28	West Nile Fever 01/2021 - 07/2004
24	COVID-19 11/2023 - 01/2020
13	Inflammation (Inflammations) 01/2023 - 01/2008
13	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021 - 02/2007
9	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2002
7	RNA Virus Infections 10/2022 - 01/2007
6	Zika Virus Infection 01/2023 - 01/2018
6	Bites and Stings (Sting) 10/2022 - 01/2012
6	HIV Infections (HIV Infection) 01/2022 - 09/2009
6	Chronic Hepatitis C 01/2015 - 01/2008
6	Melanoma (Melanoma, Malignant) 10/2014 - 09/2005
5	Neoplasms (Cancer) 01/2022 - 10/2006
5	Hepatitis C 08/2014 - 10/2004
4	Liver Diseases (Liver Disease) 01/2021 - 03/2003
3	Autoimmune Diseases (Autoimmune Disease) 05/2023 - 01/2012
3	Human Influenza (Influenza) 01/2020 - 10/2012
3	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 04/2013
3	Persistent Infection 08/2011 - 01/2002
2	Vesicular Stomatitis 01/2023 - 05/2008
2	Viremia 01/2023 - 06/2015
2	Rupture 01/2023 - 12/2019
2	Communicable Diseases (Infectious Diseases) 01/2020 - 02/2011
2	Fibrosis (Cirrhosis) 01/2018 - 04/2005
1	Breast Neoplasms (Breast Cancer) 05/2023
1	Rheumatoid Arthritis 05/2023
1	Breakthrough Infections 01/2023
1	Vascular System Injuries 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022
1	Convalescence 08/2022

Drug/Important Bio-Agent (IBA)

73	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2002
50	InterferonsIBA 11/2023 - 01/2002
31	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2002
26	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2005
21	CytokinesIBA 10/2022 - 01/2008
19	VaccinesIBA 01/2023 - 02/2013
17	Interferon Type IIBA 01/2023 - 01/2008
14	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023 - 04/2005
14	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2018 - 02/2007
13	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2023 - 07/2004
11	InflammasomesIBA 01/2023 - 04/2009
10	Viral RNAIBA 01/2023 - 04/2002
10	Pattern Recognition ReceptorsIBA 01/2019 - 12/2008
10	LigandsIBA 01/2018 - 02/2005
9	Interferon-betaIBA 01/2018 - 07/2004
8	AntigensIBA 10/2023 - 09/2011
8	RNA Helicases (RNA Helicase)IBA 01/2019 - 04/2005
8	Transcription Factors (Transcription Factor)IBA 01/2019 - 02/2005
8	Interferon-alpha (Interferon Alfa)IBA 04/2013 - 10/2004
7	ChemokinesIBA 10/2022 - 02/2010
7	Phosphotransferases (Kinase)IBA 01/2020 - 03/2002
7	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 02/2005
6	Interferon Regulatory FactorsIBA 01/2021 - 09/2008
6	Interferon LambdaIBA 01/2019 - 04/2015
6	Nucleic AcidsIBA 01/2018 - 02/2007
6	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2015 - 04/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2016
4	Small Interfering RNA (siRNA)IBA 06/2013 - 04/2005
4	NF-kappa B (NF-kB)IBA 04/2007 - 02/2005
3	Immunoglobulin G (IgG)IBA 05/2023 - 11/2017
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2007
3	Monoclonal AntibodiesIBA 07/2022 - 02/2013
3	AntibodiesIBA 10/2019 - 07/2011
3	2-5A-dependent ribonuclease (RNase L)IBA 04/2015 - 07/2006
3	Toll-Like Receptor 3IBA 02/2014 - 04/2005
3	Peptide Hydrolases (Proteases)FDA Link 08/2011 - 05/2003
3	Ribavirin (Virazole)FDA LinkGeneric 09/2009 - 01/2008
2	remdesivirIBA 11/2023 - 08/2022
2	AutoantibodiesIBA 05/2023 - 01/2012
2	CalpainIBA 01/2023 - 12/2019
2	VimentinIBA 01/2023 - 12/2019
2	Viral ProteinsIBA 01/2023 - 02/2007
2	InterleukinsIBA 10/2022 - 01/2021
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2022 - 01/2018
2	Metronidazole (Metric)FDA LinkGeneric 01/2022 - 01/2015
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2012
2	Antiviral Restriction FactorsIBA 12/2019 - 11/2016
2	NucleotidesIBA 01/2019 - 10/2014
2	Interleukin-18 (Interleukin 18)IBA 01/2018 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018 - 01/2012
2	MicroRNAs (MicroRNA)IBA 12/2016 - 01/2014
2	Poly UIBA 11/2015 - 02/2014
2	Poly I-CIBA 10/2014 - 04/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012 - 05/2008
1	Retroelements (Retrotransposon)IBA 05/2023
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 01/2023
1	Nuclear RNAIBA 01/2023
1	AngiopoietinsIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	ProdrugsIBA 01/2023
1	Small Nuclear RNA (snRNA)IBA 01/2023
1	molnupiravirIBA 10/2022
1	Sialic Acid Binding Ig-like Lectin 1IBA 10/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 08/2022
1	SolutionsIBA 08/2022

Therapy/Procedure

22	Therapeutics 10/2022 - 04/2003
2	Aftercare (After-Treatment) 01/2021 - 02/2013
2	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 01/2018